National Vision (EYE) Stock Forecast, Price & News

7 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" EYE shares.
View EYE analyst ratings or view top-rated stocks.

7 Wall Street research analysts have issued 12 month price objectives for National Vision's shares. Their EYE share price forecasts range from $24.00 to $45.00. On average, they anticipate the company's stock price to reach $30.33 in the next year. This suggests a possible upside of 16.8% from the stock's current price.
View analysts price targets for EYE or view top-rated stocks among Wall Street analysts.

National Vision's stock was trading at $38.76 at the start of the year. Since then, EYE stock has decreased by 33.0% and is now trading at $25.97.
View the best growth stocks for 2023 here.

National Vision saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,650,000 shares, an increase of 10.5% from the April 30th total of 6,020,000 shares. Based on an average daily trading volume, of 1,800,000 shares, the short-interest ratio is presently 3.7 days. Approximately 8.7% of the shares of the stock are sold short.
View National Vision's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our EYE earnings forecast.

National Vision Holdings, Inc. (NASDAQ:EYE) announced its quarterly earnings results on Thursday, May, 11th. The company reported $0.28 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.11. The business had revenue of $562.37 million for the quarter, compared to the consensus estimate of $551.42 million. National Vision had a trailing twelve-month return on equity of 3.99% and a net margin of 1.48%.

ETFs with the largest weight of National Vision (NASDAQ:EYE) stock in their portfolio include SPDR S&P Retail ETF (XRT), Invesco S&P SmallCap Consumer Discretionary ETF (PSCD), Direxion Daily Retail Bull 3X Shares (RETL), Invesco S&P SmallCap 600 QVM Multi-factor ETF (QVMS), Syntax Stratified SmallCap ETF (SSLY), SPDR S&P 600 Small Cap Growth ETF (SLYG), Inspire Small/Mid Cap ETF (ISMD) and Franklin U.S. Small Cap Multifactor Index ETF (FLQS).

National Vision announced that its board has initiated a share buyback plan on Monday, November 29th 2021, which authorizes the company to buyback $100,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 2.5% of its shares through open market purchases. Shares buyback plans are often a sign that the company's board of directors believes its stock is undervalued.

National Vision updated its FY 2023 earnings guidance on Friday, May, 12th. The company provided EPS guidance of $0.42-$0.60 for the period, compared to the consensus EPS estimate of $0.52. The company issued revenue guidance of $2.08 billion-$2.13 billion, compared to the consensus revenue estimate of $2.11 billion.

243 employees have rated National Vision Chief Executive Officer L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among the company's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other National Vision investors own include Verizon Communications (VZ), Enterprise Products Partners (EPD), AT&T (T), Carnival Co. & (CCL), Antares Pharma (ATRS), Advanced Micro Devices (AMD), Gilead Sciences (GILD), QUALCOMM (QCOM), Tanger Factory Outlet Centers (SKT) and STMicroelectronics (STM).

(EYE) raised $300 million in an initial public offering on Thursday, October 26th 2017. The company issued 15,800,000 shares at $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities served as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

National Vision trades on the NASDAQ under the ticker symbol "EYE."

National Vision's stock is owned by a number of retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (11.08%), JPMorgan Chase & Co. (7.41%), Clearbridge Investments LLC (5.52%), Macquarie Group Ltd. (4.15%), Macquarie Group Ltd. (4.15%) and Bank of New York Mellon Corp (2.96%). Insiders that own company stock include D Randolph Peeler, Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp, Ravi Acharya and Virginia A Hepner.
View institutional ownership trends.

Shares of EYE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of EYE stock can currently be purchased for approximately $25.97.

National Vision (NASDAQ:EYE) has a market capitalization of $2.03 billion and generates $2.01 billion in revenue each year. The company earns $42.12 million in net income (profit) each year or $0.37 on an earnings per share basis.

The company employs 13,975 workers across the globe.

National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The official website for the company is www.nationalvision.com. The company can be reached via phone at (770) 822-3600 or via email at investor.relations@nationalvision.com.